SCHEMBL30633327

SCHEMBL30633327

COCCNC(=O)Nc1cc(-c2ccc3[nH]nc(N)c3c2)ccn1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 19/20 0.60
▸ LRRK2 Q5S007 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26686017 1.00 MAPK1 (0.60) MAPK1LRRK2
SCHEMBL26685737 0.89 MAPK1 (0.57) MAPK1
SCHEMBL31240475 0.89 MAPK1 (0.57) MAPK1
SCHEMBL26686173 0.88 MAPK1 (0.56) MAPK1
SCHEMBL30633349 0.88 MAPK1 (0.56) MAPK1
SCHEMBL31240315 0.86 MAPK1 (0.56) MAPK1
SCHEMBL26685764 0.86 MAPK1 (0.56) MAPK1
SCHEMBL31240323 0.86 MAPK1 (0.47) MAPK1
SCHEMBL26686009 0.86 MAPK1 (0.47) MAPK1
SCHEMBL30633294 0.86 MAPK1 (0.49) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 — — CN claimed
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 — — CN disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback